MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Gray Matter Microstructural Integrity in Relation to Frontostriatal and Posterior Cortical Cognitive Performance in Parkinson’s Disease

    Q. Devignes, M. Egan, A. Kayris, S. Peltier, B. Hampstead, L. Hernandez-Garcia (Ann Arbor, USA)

    Objective: Explore relationships of frontostriatal (FS) and posterior cortical (PC) cognitive performance with gray matter (GM) microstructural integrity in Parkinson’s disease (PD). Background: The dual…
  • 2025 International Congress

    Patterns and Predictors of Cholinesterase Inhibitor Use in Dementia with Lewy Bodies

    R. Heo, A. Negida, K. Wyman-Chick, J. Bateman, F. Rodriguez-Porcel, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: The objective of this study was to identify the patterns and predictors of cholinesterase inhibitor (ChEI) prescribing in Dementia with Lewy bodies (DLB) patients.…
  • 2025 International Congress

    Observations and Strategies for Improving Recruitment and Retention of Underrepresented Populations in Movement Disorders Clinical Research Trials Conducted in a Tertiary Research Site

    I. Saraf, P. Agarwal, L. Patron (Kirkland, USA)

    Objective: To observe the improvement in one tertiary clinical site of the recruitment of underrepresented populations with a focus on the Asian demographic and note…
  • 2025 International Congress

    Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

    D. Weintraub (Philadelphia, USA)

    Objective: To assess for cognitive impairment and features of prodromal Lewy body dementia (LBD) in persons with isolated REM sleep behavior disorder (iRBD) and neuronal…
  • 2025 International Congress

    Telephone-Based Cognitive Screening for MCI to Dementia in Parkinson’s Disease

    R. Ferrucci, A. de Sandi, F. Verardo, D. Mellace, A. Marfoli, S. Zago, E. Mailland, G. Pravettoni, F. Mameli, F. Ruggiero, E. Zirone, S. Marceglia, A. Priori, F. Cogiamanian, M. Vergari, C. Manzoni, E. Aiello (Milan, Italy)

    Objective: The aim of this study is to evaluate whether telephone-based cognitive screening could be an effective and sustainable alternative to traditional in-person neuropsychological assessment.…
  • 2025 International Congress

    Poor sleep quality is one of the causes of cognitive decline in Parkinson’s disease (PD)-1

    K. Hasegawa, M. Miyashita, M. Sagawa, A. Kawanami (Kanagawa, Japan)

    Objective: The purpose of this study was to clarify the relationship between sleep disorders and cognitive function in PD by overnight electroencephalogram (EEG) and sleep…
  • 2025 International Congress

    CSF Biomarker-based Cognitive Trajectories in Parkinson’s Disease-Subjective Cognitive Decline

    J. Rodriguez-Antiguedad, A. Puig-Davi, I. Ruiz-Barrio, J. Pagonabarraga, A. Vazquez-Oliver, A. Horta-Barba, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate associations between CSF biomarkers and cognitive decline in Parkinson’s Disease-Subjective Cognitive Decline (PD-SCD). Background: The presence of cognitive complaints without objective cognitive…
  • 2025 International Congress

    Cerebral Glucose Metabolic Features of GBA-Parkinson’s Disease as a window into cognitive impairment

    P. Mitrotti, R. Calabrese, M. Picascia, L. Gallo, R. Malito, A. Panzacchi, C. Galandra, M. Todisco, R. Zangaglia, D. Perani, A. Chiti, EM. Valente, C. Tassorelli, S. Camminiti, M. Avenali (Pavia, Italy)

    Objective: to investigate cerebral glucose metabolism via fluorodeoxyglucose positron emission tomography (FDG-PET) and its correlation to clinical features in Parkinson’s disease (PD) patients with GBA1…
  • 2025 International Congress

    Parkinsonism following Chronic Disulfiram Overdose

    S. Ray, V. Kamath, B. Bairy (Bangalore, India)

    Objective: To describe the effect of chronic intake of disulfiram Background: Background- Drug induced parkinsonism is one of the commonest causes of non-degenerative parkinsonism. Typical…
  • 2025 International Congress

    Gait Characteristics and Cognitive status correlation during Dual-Task Walking in Elderly Subjects of Different Age

    S. Radovanovic, V. Markovic, N. Nedovic (Belgrade, Serbia)

    Objective: Gait characteristics relationships to cognitive status were estimated by measuring gait performance and tested cognitive status and cognitive functions in three groups of healthy…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley